Cutting edge: Chronic inflammatory liver disease in mice expressing a CD28-specific ligand

Journal of Immunology

Volumn 190, Issue 2, 2013, Pages 526-530

  Corse, Emily ^a,j   Gottschalk, Rachel A ^a,b,e   Park, Joon Seok ^a,b   Sepulveda, Manuel A ^a,f   Loke, P'ng ^c,g   Sullivan, Timothy J ^c,h   Johnson, Linda K ^d,i   Allison, James P ^a,j  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ChemoCentryx Inc   (United States)

ⁱ JAMES COOK UNIVERSITY   (Australia)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD28 SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY LIGAND; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN FC FRAGMENT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; ENZYME ANALYSIS; LIVER EXAMINATION; LIVER FIBROSIS; LIVER HYPERPLASIA; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD28; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS, AUTOIMMUNE; INFLAMMATION; INTERFERON-GAMMA; LIGANDS; MALE; MICE; MICE, TRANSGENIC; PROTEIN BINDING; SINGLE-CHAIN ANTIBODIES;

EID: 84872172665     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202621     Document Type: Article

References (27)

1. Sharpe, A. H. 2009. Mechanisms of costimulation. Immunol. Rev. 229: 5-11.
2. Bour-Jordan, H., and J. A. Bluestone. 2009. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol. Rev. 229: 41-66.
3. Pentcheva-Hoang, T., E. Corse, and J. P. Allison. 2009. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Immunol. Rev. 229: 67-87.
4. Walker, L. S., and D. M. Sansom. 2011. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat. Rev. Immunol. 11: 852-863.
5. Sullivan, T. J., J. J. Letterio, A. van Elsas, M. Mamura, J. van Amelsfort, S. Sharpe, B. Metzler, C. A. Chambers, and J. P. Allison. 2001. Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 98: 2587-2592.
6. Fife, B. T., M. D. Griffin, A. K. Abbas, R. M. Locksley, and J. A. Bluestone. 2006. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J. Clin. Invest. 116: 2252-2261.
7. Thomson, A. W., and P. A. Knolle. 2010. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10: 753-766.
8. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3: 51-62.
9. Czaja, A. J. 2010. Animal models of autoimmune hepatitis. Expert Rev. Gastroenterol. Hepatol. 4: 429-443.
10. Hardtke-Wolenski, M., F. Noyan, and E. Jaeckel. 2011. Requirements and challenges of a preclinical autoimmune hepatitis mouse model. Dig. Dis. 29: 402-410.
11. Holdener, M., E. Hintermann, M. Bayer, A. Rhode, E. Rodrigo, G. Hintereder, E. F. Johnson, F. J. Gonzalez, J. Pfeilschifter, M. P. Manns, et al. 2008. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J. Exp. Med. 205: 1409-1422.
12. Haybaeck, J., N. Zeller, M. J. Wolf, A. Weber, U. Wagner, M. O. Kurrer, J. Bremer, G. Iezzi, R. Graf, P. A. Clavien, et al. 2009. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16: 295-308.
13. National Institutes of Health (U.S.). Digestive Diseases Interagency Coordinating Committee. Liver Disease Subcommittee, and National Institutes of Health (U.S.). Action plan for liver disease research: a report of the Liver Disease Subcommittee of the Digestive Diseases Interagency Coordinating Committee. http://www2.niddk.nih.gov/NR/rdonlyres/37A98A02-9631-431A-8C30- 3F2D1B1945A2/0/ldrb-cover-toc.pdf.
14. Mieli-Vergani, G., and D. Vergani. 2011. Autoimmune hepatitis. Nat. Rev. Gastroenterol. Hepatol. 8: 320-329.
15. Longhi, M. S., M. J. Hussain, D. P. Bogdanos, A. Quaglia, G. Mieli-Vergani, Y. Ma, and D. Vergani. 2007. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 46: 472-484.
16. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6: 303-313.
17. Miyake, Y., F. Ikeda, A. Takaki, K. Nouso, and K. Yamamoto. 2011. +49A/G polymorphism of cytotoxic T-lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta-analysis. Hepatol. Res. 41: 151-159.
18. van Santen, H., C. Benoist, and D. Mathis. 2000. A cassette vector for high-level reporter expression driven by a hybrid invariant chain promoter in transgenic mice. J. Immunol. Methods 245: 133-137.
19. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
20. Washington, M. K. 2007. Autoimmune liver disease: overlap and outliers. Mod. Pathol. 20(Suppl. 1): S15-S30.
21. Krawitt, E. L. 2006. Autoimmune hepatitis. N. Engl. J. Med. 354: 54-66.
22. Oo, Y. H., S. G. Hubscher, and D. H. Adams. 2010. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int 4: 475-493.
23. Gossard, A. A., and K. D. Lindor. 2012. Autoimmune hepatitis: a review. J. Gastroenterol. 47: 498-503.
24. Manns, M. P., A. J. Czaja, J. D. Gorham, E. L. Krawitt, G. Mieli-Vergani, D. Vergani, and J. M. Vierling; American Association for the Study of Liver Diseases. 2010. Diagnosis and management of autoimmune hepatitis. Hepatology 51: 2193-2213.
25. Huang, L., G. Soldevila, M. Leeker, R. Flavell, and I. N. Crispe. 1994. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1: 741-749.
26. Toyonaga, T., O. Hino, S. Sugai, S. Wakasugi, K. Abe, M. Shichiri, and K. Yamamura. 1994. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc. Natl. Acad. Sci. USA 91: 614-618.
27. Gorham, J. D., J. T. Lin, J. L. Sung, L. A. Rudner, and M. A. French. 2001. Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J. Immunol. 166: 6413-6422.